Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.
Filed with BSE · · 1 page · English
Summary by 6ix AI
Zenotech Laboratories Limited has announced a board meeting to consider and approve its unaudited standalone financial results for a specific period. The meeting is scheduled for a date in late October. Additionally, the company has closed its trading window for shares, effective from early October until after the results are declared.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zenotech Laboratories Limited on 6ix
Story so far
- Intimation Of 37Th Annual General Meeting Of Zenotech Laboratories Limited
- Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026.
- Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026.
Earlier from Zenotech Laboratories
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Zenotech Laboratories Limited Press Release Sep 26 2026
- Closure of Trading Window
- Voting Results And Scrutinizer Report Of 37Th Annual General Meeting Held On September 25, 2026
- Zenotech Laboratories Limited Press Release Sep 25 2026
Follow Zenotech Laboratories into a list and get an email when it puts out news.
Follow Zenotech Laboratories